RecruitingNot Applicable

Prospective Study of Extended Robotic Right Hemicolectomy With Complete Mesocolic Excision for Cancer

Denmark40 participantsStarted 2020-05-18

Plain-language summary

A single-center prospective study to elucidate whether extended robot-assisted right colectomy (e-RARC) performs as well as extended open right colectomy (e-ORC) in terms of specimen quality, and in addition, whether less postoperative morbidity and shorter length of stay (LOS) can be attained. Patients with colonic cancer near the right flexure or the oral part of the transverse colon will be compared excluding the most technically demanding and frail patients in both groups. A total of 40 patients undergoing e-RARC in a prospective series will be included and compared with 44 consecutive patients previously treated with e-ORC.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Suspected or verified colonic cancer visualized by colonoscopy and on CT in the anal part of the ascending colon, in the right flexure or in the oral 2/3 of the transverse colon * Patient is 18 years or older, legally competent and able to comprehend information and give consent * Tumor is UICC stage I-III on preop CT * Operation is elective Exclusion Criteria: * Previous major open intraabdominal surgery * Ileus or other acute abdominal condition * CT scan with suspicion of T4 tumor * RITA score \> 3 (Preop risk and frailty score) * BMI \> 35 kg/m2 * Project surgeon not available

What they're measuring

Plane of dissection

Timeframe: 30 days

Lymph node count

Timeframe: 30 days

Trial details

NCT IDNCT04190589

SponsorVejle Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-12

Contact for this trial

Hans B Rahr, MD DMSc

+4520574529 hans.rahr@rsyd.dk

View on ClinicalTrials.gov More Colorectal Cancer trials